Asia backs Arysta buyout

Despite coming in the teeth of the global credit dislocation, Permira’s ¥185bn buyout of Japan’s Arysta LifeScience has closed to a blowout response. Conservatively structured, well priced and with a strong credit story, success proves that the Asian market is open to the right name. Prakash Chakravarti and Atanas Dinov report.

Financial Services